Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: Treatment outcomes in patients with comorbid arthritis

Psychosomatics

Volumn 50, Issue 4, 2009, Pages 402-412

  Wohlreich, Madelaine M ^a   Sullivan, Mark D ^b   Mallinckrodt, Craig H ^b   Chappell, Amy S ^b   Oakes, Tina M ^b   Watkin, John G ^b   Raskin, Joel ^b  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DULOXETINE; IBUPROFEN; NAPROXEN; PARACETAMOL; PLACEBO;

AGED; AGING; ARTHRITIS; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; SCORING SYSTEM; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ARTHRITIS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLACEBOS; RECURRENCE; THIOPHENES; TREATMENT OUTCOME;

EID: 67649607662     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.50.4.402     Document Type: Article

References (40)

1. Lawrence RC, Helmick CG, Arnett FC, et al: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41:778-799 (Pubitemid 28225778)
2. Zhang Y, Niu J, Kelly-Hayes M, et al: Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. Am J Epidemiol 2002; 156:1021-1027 (Pubitemid 35396931)
3. Mannoni A, Briganti MP, Di Bari M, et al: Epidemiological profile of symptomatic osteoarthritis in older adults: a population-based study in Dicomano, Italy. Ann Rheum Dis 2003; 62:576-578 (Pubitemid 36606294)
4. Picavet HS, Hazes JM: Prevalence of self-reported musculoskeletal diseases is high. Ann Rheum Dis 2003; 62:644-650 (Pubitemid 36760562)
5. Oliveria SA, Felson DT, Reed JI, et al: Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995; 38:1134-1141
6. Gallo JJ, Lebowitz BD: The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv 1999; 50:1158-1166
7. Blazer D: Depression in the elderly. N Engl J Med 1989; 320:164-166
8. Iosifescu DV, Bankier B, Fava M: Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Curr Psychiatry Rep 2004; 6:193-201 (Pubitemid 38906845)
9. Oslin DW, Datto CJ, Kallan MJ, et al: Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 2002; 50:823-828 (Pubitemid 34496677)
10. Sarzi Puttini P, Cazzola M, Boccassini L, et al: A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J Int Med Res 1988; 16:331-337 (Pubitemid 18234766)
11. Ash G, Dickens CM, Creed FH, et al: The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology (Oxford) 1999; 38:959-967 (Pubitemid 29505077)
12. Frank RG, Kashani JH, Parker JC, et al: Antidepressant analgesia in rheumatoid arthritis. J Rheumatol 1988; 15:1632-1638
13. Macfarlane JG, Jalali S, Grace EM: Trimipramine in rheumatoid arthritis: a randomized, double-blind trial in relieving pain and joint tenderness. Curr Med Res Opin 1986; 10:89-93 (Pubitemid 16080875)
14. MacNeill AL, Dick WC: Imipramine and rheumatoid factor. J Int Med Res 1976; 4(suppl 2):23-27
15. Fowler PD, MacNeill A, Spencer D, et al: Imipramine, rheumatoid arthritis, and rheumatoid factor. Curr Med Res Opin 1977; 5:241-246
16. Bird H, Broggini M: Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J Rheumatol 2000; 27:2791-2797
17. Slaughter JR, Parker JC, Martens MP, et al: Clinical outcomes following a trial of sertraline in rheumatoid arthritis. Psychosomatics 2002; 43:36-41 (Pubitemid 34214160)
18. Parker JC, Smarr KL, Slaughter JR, et al: Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum 2003; 49:766-777
19. Lin EH, Katon W, Von Korff M, et al: Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized, controlled trial. JAMA 2003; 290:2428-2429 (Pubitemid 37430542)
20. Detke MJ, Lu Y, Goldstein DJ, et al: Duloxetine, 60 mg once daily, for major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2002; 63:308-315 (Pubitemid 34456358)
21. Detke MJ, Lu Y, Goldstein DJ, et al: Duloxetine 60 mg oncedaily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002; 36:383-390 (Pubitemid 35254112)
22. Goldstein DJ, Mallinckrodt C, Lu Y, et al: Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry 2002; 63:225-231 (Pubitemid 34407082)
23. Goldstein DJ, Lu Y, Detke MJ, et al: Duloxetine in the treatment of depression: a double-blind, placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004; 24:389-399 (Pubitemid 38944137)
24. Nelson JC, Wohlreich MM, Mallinckrodt CH, et al: Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatry 2005; 13:227-235 (Pubitemid 41031091)
25. Wohlreich MM, Mallinckrodt CH, Watkin JG, et al: Duloxetine for the long-term treatment of major depressive disorder in patients age 65 and older: an open-label study. BMC Geriatr 2004; 4:11
26. Raskin J, Wiltse CG, Siegal A, et al: Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 2007; 164:900-909 (Pubitemid 46972905)
27. Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33 (Pubitemid 29001829)
28. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
29. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
30. Maier W, Philipp M: Improving the assessment of severity of depressive states: a reduction of the Hamilton depression scale. Pharmacopsychiatry 1985; 18:114-115 (Pubitemid 15137667)
31. Cleary P, Guy W: Factor analysis of the Hamilton depression scale. Drugs Exp Clin Res 1977; 1:115-120
32. Guy W: ECDEU Assessment Manual for Psychopharmacology, revised 1976. Rockville, MD, National Institutes of Mental Health, 1976
33. Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17:37-49
34. DeLoach LJ, Higgins MS, Caplan AB, et al: The visual-analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 1998; 86:102-106
35. Fava M, Mallinckrodt CH, Detke MJ, et al: The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004; 65:521-530
36. Dickens C, Jackson J, Tomenson B, et al: Association of depression and rheumatoid arthritis. Psychosomatics 2003; 44:209-215
37. Bao Y, Sturm R, Croghan TW: A national study of the effect of chronic pain on the use of health care by depressed persons. Psychiatr Serv 2003; 54:693-697 (Pubitemid 36752961)
38. Goldstein DJ, Lu Y, Detke MJ, et al: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116(1-2):109-118 (Pubitemid 40828506)
39. Arnold LM, Lu Y, Crofford LJ, et al: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50:2974-2984 (Pubitemid 39209537)
40. Turner JA, Deyo RA, Loeser JD, et al: The importance of placebo effects in pain treatment and research. JAMA 1994; 271:1609-1614